Goldman Sachs Group Inc Fortress Biotech, Inc. Transaction History

Goldman Sachs Group Inc

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 May 14, 2024	BUY	$0.28 - $0.65 $45,775 - $106,264	163,484 New	163,484 $47,000
Q3 2023 Nov 14, 2023	BUY	$0.28 - $0.65 $146 - $339	523 Added 0.32%	163,484 $47,000
Q2 2023 May 14, 2024	SELL	$0.49 - $0.82 $2,135 - $3,574	-4,359 Reduced 2.61%	162,961 $89,000
Q2 2023 Aug 14, 2023	SELL	$0.49 - $0.82 $2,135 - $3,574	-4,359 Reduced 2.61%	162,961 $89,000
Q1 2023 May 14, 2024	BUY	$0.65 - $1.1 $2,159 - $3,655	3,323 Added 2.03%	167,320 $137,000

Q1 2023 May 11, 2023	BUY	$0.65 - $1.1 $2,159 - $3,655	3,323 Added 2.03%	167,320 $137,000
Q4 2022 May 14, 2024	BUY	$0.48 - $0.88 $168 - $308	350 Added 0.21%	163,997 $108,000
Q4 2022 Feb 13, 2023	BUY	$0.48 - $0.88 $168 - $308	350 Added 0.21%	163,997 $108,000
Q3 2022 May 14, 2024	SELL	$0.79 - $22.0 $18,147 - $505,362	-22,971 Reduced 12.31%	163,647 $141,000
Q3 2022 Nov 10, 2022	SELL	$0.79 - $22.0 $18,147 - $505,362	-22,971 Reduced 12.31%	163,647 $0
Q2 2022 May 14, 2024	BUY	$0.8 - $1.5 $149,294 - $279,927	186,618 New	186,618 $157,000
Q2 2022 Aug 15, 2022	SELL	$0.8 - $1.5 $53,086 - $99,537	-66,358 Reduced 26.23%	186,618 $157,000
Q1 2022 May 16, 2022	BUY	$1.24 - $2.75 $26,646 - $59,094	21,489 Added 9.28%	252,976 $344,000
Q4 2021 Feb 14, 2022	SELL	$2.42 - $3.65 $8,315 - $12,541	-3,436 Reduced 1.46%	231,487 $579,000
Q3 2021 Nov 10, 2021	BUY	$2.82 - $3.7 $662,482 - $869,215	234,923 New	234,923 $757,000

1.01M

Ticker FBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,735,000
Market Cap $194M
Description
Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox for severe acne; Exelderm cream for ringworm and jock itch sympt...

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

Stay updated on Goldman Sachs Group Inc with notifications on news.